38693554|t|N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer's disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk.
38693554|a|BACKGROUND: Aberrant neuronal Sigma-1 receptor (Sig-1r)-mediated endoplasmic reticulum (ER)- mitochondria signaling plays a key role in the neuronal cytopathology of Alzheimer's disease (AD). The natural psychedelic N, N-dimethyltryptamine (DMT) is a Sig-1r agonist that may have the anti-AD potential through protecting neuronal ER-mitochondrial interplay. METHODS: 3xTG-AD transgenic mice were administered with chronic DMT (2 mg/kg) for 3 weeks and then performed water maze test. The Abeta accumulation in the mice brain were determined. The Sig-1r level upon DMT treatment was tested. The effect of DMT on the ER-mitochondrial contacts site and multiple mitochondria-associated membrane (MAM)-associated proteins were examined. The effect of DMT on calcium transport between ER and mitochondria and the mitochondrial function were also evaluated. RESULTS: chronic DMT (2 mg/kg) markedly alleviated cognitive impairment of 3xTG-AD mice. In parallel, it largely diminished Abeta accumulation in the hippocampus and prefrontal cortex. DMT restored the decreased Sig-1r levels of 3xTG-AD transgenic mice. The hallucinogen reinstated the expression of multiple MAM-associated proteins in the brain of 3xTG-AD mice. DMT also prevented physical contact and calcium dynamic between the two organelles in in vitro and in vivo pathological circumstances. DMT modulated oxidative phosphorylation (OXPHOS) and ATP synthase in the in vitro model of AD. CONCLUSION: The anti-AD effects of DMT are associated with its protection of neuronal ER-mitochondria crosstalk via the activation of Sig-1r. DMT has the potential to serve as a novel preventive and therapeutic agent against AD.
38693554	0	23	N, N-Dimethyltryptamine	Chemical	MESH:D004130
38693554	61	80	Alzheimer's disease	Disease	MESH:D000544
38693554	223	229	Sig-1r	Gene	18391
38693554	341	360	Alzheimer's disease	Disease	MESH:D000544
38693554	362	364	AD	Disease	MESH:D000544
38693554	391	414	N, N-dimethyltryptamine	Chemical	MESH:D004130
38693554	416	419	DMT	Chemical	MESH:D004130
38693554	426	432	Sig-1r	Gene	18391
38693554	464	466	AD	Disease	MESH:D000544
38693554	542	549	3xTG-AD	CellLine	CVCL:RN76
38693554	561	565	mice	Species	10090
38693554	597	600	DMT	Chemical	MESH:D004130
38693554	663	668	Abeta	Gene	14961
38693554	689	693	mice	Species	10090
38693554	721	727	Sig-1r	Gene	18391
38693554	739	742	DMT	Chemical	MESH:D004130
38693554	779	782	DMT	Chemical	MESH:D004130
38693554	834	866	mitochondria-associated membrane	Gene	54343
38693554	868	871	MAM	Gene	54343
38693554	922	925	DMT	Chemical	MESH:D004130
38693554	929	936	calcium	Chemical	MESH:D002118
38693554	1044	1047	DMT	Chemical	MESH:D004130
38693554	1078	1098	cognitive impairment	Disease	MESH:D003072
38693554	1102	1109	3xTG-AD	CellLine	CVCL:RN76
38693554	1110	1114	mice	Species	10090
38693554	1151	1156	Abeta	Gene	14961
38693554	1212	1215	DMT	Chemical	MESH:D004130
38693554	1239	1245	Sig-1r	Gene	18391
38693554	1256	1263	3xTG-AD	CellLine	CVCL:RN76
38693554	1275	1279	mice	Species	10090
38693554	1336	1339	MAM	Gene	54343
38693554	1376	1383	3xTG-AD	CellLine	CVCL:RN76
38693554	1384	1388	mice	Species	10090
38693554	1390	1393	DMT	Chemical	MESH:D004130
38693554	1430	1437	calcium	Chemical	MESH:D002118
38693554	1525	1528	DMT	Chemical	MESH:D004130
38693554	1616	1618	AD	Disease	MESH:D000544
38693554	1641	1643	AD	Disease	MESH:D000544
38693554	1655	1658	DMT	Chemical	MESH:D004130
38693554	1754	1760	Sig-1r	Gene	18391
38693554	1762	1765	DMT	Chemical	MESH:D004130
38693554	1845	1847	AD	Disease	MESH:D000544
38693554	Negative_Correlation	MESH:D004130	MESH:D000544
38693554	Association	MESH:D004130	54343
38693554	Negative_Correlation	MESH:D004130	MESH:D003072
38693554	Association	MESH:D000544	18391
38693554	Negative_Correlation	MESH:D002118	MESH:D004130
38693554	Negative_Correlation	MESH:D004130	14961
38693554	Positive_Correlation	MESH:D004130	18391

